InvestorsObserver
×
News Home

Does Altimmune Inc (ALT) Have What it Takes to be in Your Portfolio?

Friday, September 25, 2020 09:46 AM | InvestorsObserver Analysts

Mentioned in this article

Does Altimmune Inc (ALT) Have What it Takes to be in Your Portfolio?

The 60 rating InvestorsObserver gives to Altimmune Inc (ALT) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 75 percent of stocks in the Biotechnology industry, ALT’s 60 overall rating means the stock scores better than 60 percent of all stocks.

Overall Score - 60
ALT has an Overall Score of 60. Find out what this means to you and get the rest of the rankings on ALT!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. Investors Observer makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.

This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Altimmune Inc Stock Today?

Altimmune Inc (ALT) stock is up 5.99% while the S&P 500 is unchanged 0% as of 9:45 AM on Friday, Sep 25. ALT is higher by $0.72 from the previous closing price of $12.03 on volume of 82,317 shares. Over the past year the S&P 500 is higher by 9.03% while ALT is higher by 537.50%. ALT lost -$2.21 per share the over the last 12 months.

Click Here to get the full Stock Score Report on Altimmune Inc (ALT) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App